Review

Nature Reviews Cancer 10, 489-503 (July 2010) | doi:10.1038/nrc2875

Sphingosine 1-phosphate and cancer

Nigel J. Pyne1 & Susan Pyne1  About the authors

Top

There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer. S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival. This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase. This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.

Author affiliations

  1. Cell Biology Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, UK.
    Email: n.j.pyne@strath.ac.uk; Email: susan.pyne@strath.ac.uk

Published online 17 June 2010

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

REVIEWS

Biologically active sphingolipids in cancer pathogenesis and treatment

Nature Reviews Cancer Review (01 Aug 2004)

Sphingosine-1-phosphate: an enigmatic signalling lipid

Nature Reviews Molecular Cell Biology Review (01 May 2003)

See all 7 matches for Reviews

NEWS AND VIEWS

Cell biology A brake on lipid synthesis

Nature News and Views (25 Feb 2010)

Ceramide lances the lungs

Nature Medicine News and Views (01 Feb 2004)